Railway Pension Investments’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-70,600
Closed -$20.3M – 206
2025
Q2
$20.3M Hold
70,600
– – 0.29% 104
2025
Q1
$21.8M Buy
70,600
+2,700
+4% +$925K 0.31% 99
2024
Q4
$24M Buy
67,900
+1,700
+3% +$625K 0.32% 98
2024
Q3
$23.7M Hold
66,200
– – 0.28% 109
2024
Q2
$21.1M Buy
66,200
+56,500
+582% +$15M 0.25% 108
2024
Q1
$2.23M Hold
9,700
– – 0.02% 197
2023
Q4
$2.13M Buy
+9,700
New +$2.24M 0.02% 195
2019
Q4
– Sell
-30,340
Closed -$2.42M – 370
2019
Q3
$2.42M Sell
30,340
-74,943
-71% -$6.04M 0.03% 319
2019
Q2
$8.22M Buy
105,283
+1,019
+1% +$95.3K 0.11% 192
2019
Q1
$12.2M Buy
104,264
+28,199
+37% +$3.29M 0.17% 136
2018
Q4
$8.28M Buy
+76,065
New +$8.82M 0.17% 144

Other funds holding UTHR

Railway Pension Investments's UTHR Position: Q3 2025 in Review

Railway Pension Investments sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 70,600 shares — an estimated $20.3M sold.

Railway Pension Investments first reported a position in UTHR in Q4 2018 and held it in 11 quarters. The position peaked at $24M in Q4 2024. 708 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Railway Pension Investments reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Railway Pension Investments sold 70,600 United Therapeutics shares in Q3 2025, an estimated $20.3M.
  • Railway Pension Investments first reported a position in United Therapeutics in Q4 2018 and held it in 11 quarters.
  • Railway Pension Investments's United Therapeutics position peaked at $24M in Q4 2024.
  • 708 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Railway Pension Investments's 13F filing for Q3 2025, filed 22 Oct 2025.